The licensing of the vaccine means that the manufacturer can stockpile and widely distribute this vaccine to African countries at risk of Ebola virus disease outbreaks. Keep Reading
While the quarantine potentially conferred a significant public health benefit in slowing transmission, CDC’s assessment is that it may not have been sufficient to prevent transmission among individuals on the ship. Keep Reading
The Biomedical Advanced Research and Development Authority (BARDA), a component of ASPR, will provide expertise and reallocated funds to support the vaccine’s development. Keep Reading
Coronavirus may be in the headlines, but it's still flu season, and a weird one at that — officials are seeing a new spike in flu activity as a second strain of flu hits on the heels of the first. Keep Reading
Leidos has been awarded a follow-on prime contract by the Centers for Disease Control and Prevention (CDC) to provide technical support services for the Center for Preparedness and Response under a Blanket Purchase Agreement. Keep Reading
The International Civil Aviation Organization has produced some preliminary forecasts relating to the expected economic impacts from COVID-19 travel bans. Keep Reading
Janssen and the Biomedical Advanced Research and Development Authority (BARDA), a component of ASPR, will share research and development costs and expertise to help accelerate Janssen's investigational novel coronavirus vaccine into clinical evaluation. Keep Reading
The memo provides information on various human resources (HR) flexibilities that agencies and employees may use during periods when employees are subject to quarantine or isolation in connection with 2019-nCoV. Keep Reading
Bipartisan Commission on Biodefense discusses zoonotic origins, trying to slow progression and the danger of antibiotic resistance. Keep Reading
This brings the total of number of COVID-19 cases in the United States to 14. There are likely to be additional cases in the coming days and weeks, including among other people recently returned from Wuhan. Keep Reading